/ Print /

Leukemia-Lymphoma

Top Considerations in Pediatric Cancer Treatment: What Payers Should KnowA Stanford expert describes ideal treatment locations, common barriers, and how payers could better support patients and families.
Cancer Vaccine to Prevent Breast, Ovarian Cancer Recurrence Could be CloseIn partnership with the several big-name cancer centers, one company has commenced clinical trials. Find out how this cancer vaccine would work.
Five factors driving up the cost of oncology drugsThe high cost of specialty drugs continues to plague the healthcare industry. Here’s why.
CAR T-cell therapies in treating lymphoma: Pros and consCatherine Bollard, MD, discusses the success rate of CAR T-cell treatments, remaining obstacles, and top payer considerations.
Three things health execs need to know about CAR T-cell therapyHere’s your quick guide to understanding how CAR T-cell therapy could affect patients and payers.
What oncologists say about new cancer treatment optionsA new report from Cardinal Health Specialty Solutions gives behind-the-scenes perspectives from oncologists about CAR-T cell therapies, biosimilars and AML therapies (or genomic medicines)
Ovarian cancer could be next application for CAR T-cell therapyWhile CAR T-cell therapy has been proven to work for liquid—or blood—cancers, the challenge has been to apply this technology to solid tumors.
Treating frail elderly patients with multiple myeloma requires different approachTransplant eligibility issues and drug regimen options raise difficult questions when treating older multiple myeloma patients.
Patient experience with immunotherapy: 4 things health execs need to knowCAR T-cell therapies and other immunotherapy give this oncologist’s cancer patients hope for a better quality of life.
Top tech advancements improving breast cancer screening
Top tech advancements improving breast cancer screeningEarly detection of breast cancer continues to be the best way to save lives and decrease healthcare costs over time, and new technology could help.